Brenda Ng, Ph.D., is currently managing clinical trials in HIV at Gilead Sciences. Her postdoctoral work involved posttranslational regulation of transcription factors in hedgehog signaling. She also has prior teaching experience as adjunct faculty at the University of San Francisco.